Novel therapeutic opportunities in neoadjuvant setting in urothelial cancers: a new horizon opened by molecular classification and immune checkpoint inhibitors

ML Iacovino, CC Miceli, M De Felice, B Barone… - International journal of …, 2022 - mdpi.com
Muscle invasive bladder cancer (MIBC) is a widespread malignancy with a worse prognosis
often related to a late diagnosis. For early-stage MIBC pts, a multidisciplinary approach is …

The role of imaging in bladder cancer diagnosis and staging

SJ Galgano, KK Porter, C Burgan, S Rais-Bahrami - Diagnostics, 2020 - mdpi.com
Bladder cancer (BC) is the most common cancer of the urinary tract in the United States.
Imaging plays a significant role in the management of patients with BC, including the …

[HTML][HTML] PET/CT in bladder cancer: an update

K Bouchelouche - Seminars in nuclear medicine, 2022 - Elsevier
In the urinary tract, bladder cancer is the most common malignancy. It is a heterogenous
cancer type with approximately 30% presenting as muscle invasive bladder cancer with a …

The role of 18F-FDG PET/CT in guiding precision medicine for invasive bladder carcinoma

A Girard, H Vila Reyes, H Shaish, JF Grellier… - Frontiers in …, 2020 - frontiersin.org
Bladder cancer (BC) is the 10th most common cancer worldwide. Approximately one quarter
of patients with BC have muscle-invasive disease (MIBC). Muscle-invasive disease carries a …

18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in muscle-invasive bladder cancer

SMH Einerhand, EJ van Gennep… - Current opinion in …, 2020 - journals.lww.com
18F-fluoro-2-deoxy-D-glucose positron emission tomography/co... : Current Opinion in
Urology 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed …

Imaging features of solid renal masses

M Galia, D Albano, A Bruno, A Agrusa… - The British journal of …, 2017 - academic.oup.com
The widespread use of abdominal imaging techniques has increased the detection of solid
renal masses over the past years. Imaging plays a crucial role in the management and …

DWI as an imaging biomarker for bladder cancer

S Yoshida, T Takahara, TC Kwee… - American Journal of …, 2017 - Am Roentgen Ray Soc
OBJECTIVE. DWI has been increasingly applied in the management of bladder cancer. In
this article, we discuss the role of DWI as an imaging biomarker for bladder cancer …

Assessing the performance of 18F-FDG PET/CT in bladder cancer: a narrative review of current evidence

M Bacchiani, V Salamone, E Massaro, A Sandulli… - Cancers, 2023 - mdpi.com
Simple Summary Lymph node involvement is a prognostic determinant in the diagnostic
work-up and management of muscle-invasive bladder cancer. Thus, it is crucial to provide …

Predicting recurrence of non-muscle-invasive bladder cancer: current techniques and future trends

AT Shalata, M Shehata, E Van Bogaert, KM Ali… - Cancers, 2022 - mdpi.com
Simple Summary Non-muscle-invasive bladder cancer is associated with its high rates of
progression and recurrence, the proper diagnosis and management can save lives. Bladder …

The increasing indications of FDG-PET/CT in the staging and management of Invasive Bladder Cancer

NP Omorphos, A Ghose, JDB Hayes, A Kandala… - … Oncology: Seminars and …, 2022 - Elsevier
The management of locally advanced muscle invasive bladder cancer (MIBC) often
necessitates neo-adjuvant chemotherapy (NAC) to eliminate any micro-metastatic disease …